TETSUMI YOSIDA

Last Updated :2022/08/02

Affiliations, Positions
Hiroshima University Hospital, Assistant Professor
E-mail
yoshidathiroshima-u.ac.jp

Basic Information

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical internal medicine;Hematology

Research Keywords

  • Lymphoid malignancies
  • Hematological malignancies
  • Hematopoietic stem cells
  • Transplantation

Educational Activity

Course in Charge

  1. 2022, Undergraduate Education, Year, Clinical diagnosis and treatment II
  2. 2022, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2022, Undergraduate Education, Intensive, Practice of Medicine II

Research Activities

Academic Papers

  1. ★, Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma., Blood Cancer J, 4, e245-e245
  2. ★, All-trans retinoic acid and interferon-alpha increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors., Blood Cancer J, 6(5), e421-e421
  3. All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemia., Clin Transl Immunology, 5(12), e116-e116
  4. ★, T cells bearing anti-CD19 and/or anti-CD38 chimeric antigen receptors effectively abrogate primary double-hit lymphoma cells., J Hematol Oncol, 10(1), 116-116
  5. ★, Mantle cell lymphoma superimposed on multicentric Castleman's disease., J Clin Exp Hematop, 51(2), 147-150
  6. ★, Lung involvement at initial presentation in blastic plasmacytoid dendritic cell neoplasm lacking cutaneous lesion., Ann Hematol, 92(2), 269-270
  7. ★, Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant., Ann Hematol, 92(5), 711-713
  8. ★, Concurrent administration of darbepoetin alfa, cyclosporine A, and prednisolone is useful for T cell large granular lymphocyte leukemia associated with myelodysplastic syndrome complicated by Coombs-negative hemolytic anemia., Ann Hematol, 93(11), 1937-1939
  9. ★, Successful treatment with low-dose dasatinib in a patient with chronic eosinophilic leukemia intolerant to imatinib., The Japanese journal of clinical hematology, 52(7), 546-550
  10. ★, Successful treatment with bortezomib for a patient with plasma cell leukemia accompanied by severe hyperbilirubinemia., The Japanese journal of clinical hematology, 53(1), 92-96

Publications such as books

  1. 2019, Human Monoclonal Antibodies Methods and Protocols Second Edition, 13 Basic Procedures for Detection and Cytotoxicity of Chimeric Antigen Receptors, Humana Press, 2019, Scholarly Book, Joint work, 英語, Mihara K, Yoshida T, Joyeeta Bhattacharyya, etc., 978-1-4939-8958-4, 480, 299-306

Invited Lecture, Oral Presentation, Poster Presentation

  1. Adult T-Cell Leukemia/Lymphoma Cells Were Eliminated By T Cells With Anti-CD38 Chimeric Antigen Receptor Through CD38 Expression Induced By All-Trans Retinoic Acid., Yoshida T, Mihara K, Kitanaka A, Shimada K, Morishita K, Takihara Y, Ichinohe T, The 55th Annual Meeting of American Society of Hematology, 2013/12/07, Without Invitation, English, American Society of Hematology, New Orleans, LA, USA.
  2. Establishment and genetic analysis of bone marrow mesenchymal cell clones supporting proliferation of CD34+ umbilical cord blood cells., Yoshida T, Mihara K, Mino T, Campana D, Takihara Y, Ichinohe T, The 12th Stem Cell Research Symposium, 2014/05/30, Without Invitation, English, Fukuoka
  3. Patterns Of IgH Rearrangement Can Predicts Prognosis of Diffuse Large B-cell Lymphoma in Association with CDC25A Overexpression., Yoshida T, Mihara K, Ohtaki M, Shiroma N, Arihiro K, Sasaki N, Ichinohe T, ASH Meeting on Lymphoma Bioligy, 2018/08/02, Without Invitation, English, Chantilly VA, USA
  4. Primary adrenal diffuse large B cell lymphoma with concomitant CNS involvement at initial findings., Tetsumi Yoshida, Tatsuji Mino, Taro Edahiro, Hisao Nagoshi, Takakazu Kawase, Masatoshi Nishizawa, Noriyasu Fukushima, Tatsuo Ichinohe, The 82nd Annual Meeting of the Japanese Society of Hematology, 2020/10/10, Without Invitation, English, Japanese Society of Hematology, Kyoto(Virtual)